TVTX
Travere Therapeutics Inc
$59.99
1.58 (2.57%) Today
— up— down
Market Cap
$5.65B+149.5%
Revenue (TTM)
$588.24M+77.1%
Net Income (TTM)
$-46,067,246
$-46,067,246EPS (TTM)
-0.50
-0.50Shares Out
92.99M
92.99MForward P/E
32.37
32.37Open
$59.99
$59.99Previous Close
$61.57
$61.57Day Range
$59.33 – $61.87
$59.33 – $61.8752-Week Range
$22.59 – $68.73
$22.59 – $68.73Beta
1.07
1.07Volume
1.55M
1.55MAvg Volume
1.74M
1.74MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout TVTX
Martin Shkreli is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
Related
News
N/AN/AN/A
Guggenheim Maintains Buy on Travere Therapeutics, Raises Price Target to $89
Benzinga · 5d ago
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in Focal Segmental Glomerulosclerosis
Yahoo · 6d ago
Travere Therapeutics (TVTX) Sets CEO Handover For December 2026
Yahoo · 1w ago